7 completed, 6 recruiting, 1 terminated, 1 unknown. 15 Phase 2, 3 Phase 3, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 15 | Completed 7, Recruiting 6, Terminated 1, Unknown 1 |
| Phase 3 | 3 | Completed 1, Recruiting 1, Terminated 1 |
| Phase 1 | 2 | Completed 1, Recruiting 1 |
Follow Mobility Limitation: new trials by email Literature Review of Mobility Limitation trials Research Report on Mobility Limitation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Living Independence Through Functional Training Task-oriented resistance exercise - Mobility Limitation, Cognitive Impairment | Phase 1 / Phase 2 | Recruiting | University of Florida | 15 | 2026-01-06 | 2026-07-31 |
| Impact of Brief Daily Functional Resistance Training on Lower Extremity Physical Performance Functional Activity Strength Training - Mobility Limitation | Phase 2 / Phase 3 | Recruiting | Milton S. Hershey Medical Center | 360 | 2025-04-09 | 2026-07-22 |
| Response to Exercise and Nitric Oxide in PAD Supervised Treadmill Exercise, Attention Control, Nitrate-Rich Beetroot Juice + supervised exercise therapy - Peripheral Artery Disease, Exercise | Phase 2 | Recruiting | Northwestern University | 200 | 2025-01-23 | 2026-07-27 |
| Fisetin to Reduce Senescence and Mobility Impairment in PAD Fisetin, Placebo - Peripheral Arterial Disease, Aging | Phase 2 | Recruiting | Northwestern University | 34 | 2024-09-30 | 2026-11-16 |
| Passive Stretching in Peripheral Arterial Disease Patients Calf Plantar flexion, Dietary nitrate - Peripheral Arterial Disease, Walking, Difficulty | Phase 2 | Recruiting | University of Wisconsin, La Crosse | 64 | 2024-05-20 | 2025-04-02 |
| Heat Therapy, Functional Capacity, and Vascular Health in Older Adults Home-based leg heat therapy, Home-based sham therapy - Aging Well, Walking, Difficulty | Phase 1 / Phase 2 | Completed | University of North Texas Health Science Center | 21 | 2022-11-03 | 2026-06-05 |
| Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury Testosterone Enanthate, Locomotor Training - Spinal Cord Injury, Spinal Cord Injuries | Phase 2 | Recruiting | North Florida Foundation for Research and Education | 21 | 2021-01-31 | 2025-05-06 |
| Adrabetadex to Treat Niemann-Pick Type C1 (NPC1) Disease Adrabetadex - Niemann-Pick Disease, Type C | Phase 2 / Phase 3 | Terminated | Mandos LLC | 66 | 2015-12-23 | 2023-08-29 |
| VTS-270 to Treat Niemann-Pick Type C1 (NPC1) Disease Parts A/B: Adrabetadex, Parts A/B: Sham Control - Niemann-Pick Disease, Type C | Phase 2 / Phase 3 | Completed | Mandos LLC | 56 | 2015-10-01 | 2023-02-22 |
| Effects of Denosumab on Periprosthetic Bone After Total Hip Arthroplasty denosumab - Osteoarthritis, Hip, Ambulation Difficulty | Phase 2 | Completed | Hans Mallmin | 64 | 2012-08-07 | 2017-04-05 |
| Experimental Control Investigation of the Impact of Assistive Technology on the User-caregiver Dyad: a Multi-site Trial Assistive technology updating and tune up intervention - Mobility Limitations | Phase 2 | Completed | Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal | 88 | 2009-06-01 | 2014-02-19 |
| Effects of Game-based Balance Exercise for Older Adults With Fall History game-based balance exercises - Mobility Limitation | Phase 2 | Completed | University of Manitoba | 30 | 2007-08-01 | 2011-06-27 |
| The APOS System: Effects on Gait, Mobility and QOL in Patients With Parkinson's Disease APOS System - biomechanical wedge shoe - Idiopathic Parkinson's Disease | Phase 2 | Unknown | Tel-Aviv Sourasky Medical Center | 60 | 2007-08-01 | 2007-07-10 |
| Restoring Skill in Walking gait intervention - Mobility Limitation | Phase 2 | Completed | University of Pittsburgh | 48 | 2005-11-01 | 2007-12-13 |
| Increasing Physical Activity Among Overweight Women With Mobility Disabilities. Personalized exercise programme (PEP) - Obesity | Phase 2 | Completed | Centers for Disease Control and Prevention | 96 | 2004-10-01 | 2019-07-26 |
Cognitive Dysfunction (3) · Motor Activity (3) · Peripheral Arterial Disease (3) · Deglutition Disorders (2) · Disease (2) · Intermittent Claudication (2) · Niemann-Pick Disease, Type C (2) · Bone Resorption (1) · Central Nervous System Diseases (1) · Endocrine System Diseases (1) · Gait Disorders, Neurologic (1) · Genital Diseases, Male (1) · Gonadal Disorders (1) · Hyperemia (1)
Pathological Conditions, Signs and Symptoms (15) · Signs and Symptoms (15) · Cardiovascular Diseases (4) · Vascular Diseases (4) · Arterial Occlusive Diseases (3) · Arteriosclerosis (3) · Atherosclerosis (3) · Behavior (3) · Brain Diseases (3) · Central Nervous System Diseases (3) · Cognition Disorders (3) · Mental Disorders (3) · Nervous System Diseases (3) · Neurocognitive Disorders (3) · Nutritional and Metabolic Diseases (3)
2-Hydroxypropyl-beta-cyclodextrin (2) · Cyclodextrins (2) · Denosumab (1) · fisetin (1) · testosterone enanthate (1)
Mandos LLC (2) · Northwestern University (2) · Centers for Disease Control and Prevention (1) · Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal (1) · Hans Mallmin (1) · Milton S. Hershey Medical Center (1) · North Florida Foundation for Research and Education (1) · Tel-Aviv Sourasky Medical Center (1) · University of Florida (1) · University of Manitoba (1) · University of North Texas Health Science Center (1) · University of Pittsburgh (1) · University of Wisconsin, La Crosse (1)
United States (11) · Australia (2) · Canada (2) · France (2) · Germany (2) · New Zealand (2) · Singapore (2) · Turkey (Türkiye) (2) · United Kingdom (2) · Spain (1) · Sweden (1) · Switzerland (1)
Chiung-ju Liu Associate Professor, phD (1) · Dana M Otzel, Phd (1) · Hans Mallmin, MD, PhD (1) · Jacob T Caldwell, Ph.D. (1) · James Rimmer, Ph.D. (1) · Jessie VanSwearingen, PhD, PT (1) · Joshua F Yarrow, PhD (1) · Louise Demers, PhD (1) · Maggie Nellissery, Ph.D. (1) · Nils Hailer, MD, PhD (1) · Nir Giladi, MD (1) · Tony Szturm, BSc(PT), PhD (1)
PMID 19459233, PMID 21799138, PMID 22003158, PMID 31589776, PMID 40525490, PMID 40584156, PMID 41921101, PMID 42035974
2015 (2), R01AG079938 (1)